Three Cryptocurrencies to Hold in 2021
In 2021, Dogecoin went up over 12,000%. SafeMoon went up more than 20,000%...

But if you missed those gains, there is still time to get in on the digital currency boom.

Luke Lango – InvestorPlace’s resident crypto expert – just released the names of 3 tokens every investor should own in a free report.
Click here to claim your copy today.

HGEN Insider Trading (Humanigen)

Insider Ownership Percentage: 27.30%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $53,231,687.83

Humanigen Insider Trading History Chart

This chart shows the insider buying and selling history at Humanigen by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Humanigen Share Price & Price History

Current Price: $16.06
Price Change: Price Decrease of -0.52 (-3.14%)
As of 07/30/2021 04:50 PM ET

This chart shows the closing price history over time for HGEN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Learn to Customize Your Own Options Trading Strategy
This guide will help you evaluate and analyze your trading plan to create a custom options trading strategy tailored to your risk profile and market outlook. Learn how to take your trading to the next level.
Download your FREE Options Strategy Guide Today!

Humanigen Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/23/2021Dale ChappellInsiderSell5,584$17.04$95,151.36View SEC Filing Icon  
7/21/2021Dale ChappellInsiderSell132,764$17.14$2,275,574.96View SEC Filing Icon  
7/14/2021Dale ChappellInsiderSell15,177$17.06$258,919.62View SEC Filing Icon  
7/8/2021Dale ChappellInsiderSell48,010$17.17$824,331.70View SEC Filing Icon  
6/25/2021Dale ChappellInsiderSell1,000,000$17.80$17,800,000.00View SEC Filing Icon  
6/23/2021Dale ChappellInsiderSell133,126$18.28$2,433,543.28View SEC Filing Icon  
6/18/2021Dale ChappellInsiderSell402,480$18.50$7,445,880.00View SEC Filing Icon  
6/16/2021Dale ChappellInsiderSell158,486$19.41$3,076,213.26View SEC Filing Icon  
6/14/2021Cameron DurrantCEOSell81,441$20.64$1,680,942.24View SEC Filing Icon  
6/8/2021Edward P JordanInsiderSell14,700$20.08$295,176.0014,700View SEC Filing Icon  
6/4/2021Dale ChappellInsiderSell127,084$18.46$2,345,970.64View SEC Filing Icon  
6/2/2021Dale ChappellInsiderSell76,126$19.01$1,447,155.26View SEC Filing Icon  
3/11/2021Bay Ltd. NomisMajor ShareholderSell119,201$16.02$1,909,600.0255,632,469View SEC Filing Icon  
3/9/2021Bay Ltd. NomisMajor ShareholderSell83,568$17.24$1,440,712.3255,632,469View SEC Filing Icon  
3/1/2021Bay Ltd. NomisMajor ShareholderSell46,505$19.02$884,525.10
2/19/2021Bay Ltd. NomisMajor ShareholderSell37,300$23.50$876,550.005,845,470View SEC Filing Icon  
2/17/2021Bay Ltd. NomisMajor ShareholderSell9,700$19.92$193,224.005,845,470View SEC Filing Icon  
2/13/2021Bay Ltd. NomisMajor ShareholderSell16,423$19.68$323,204.645,871,593View SEC Filing Icon  
2/10/2021Bay Ltd. NomisMajor ShareholderSell10,875$21.39$232,616.255,908,684View SEC Filing Icon  
2/8/2021Bay Ltd. NomisMajor ShareholderSell17,732$20.70$367,052.405,908,684View SEC Filing Icon  
2/4/2021Bay Ltd. NomisMajor ShareholderSell47,862$21.88$1,047,220.565,999,278View SEC Filing Icon  
2/2/2021Bay Ltd. NomisMajor ShareholderSell722$20.03$14,461.665,999,278View SEC Filing Icon  
1/25/2021Bay Ltd. NomisMajor ShareholderSell23,140$19.23$444,982.206,093,140View SEC Filing Icon  
1/22/2021Bay Ltd. NomisMajor ShareholderSell71,892$20.08$1,443,591.366,093,140View SEC Filing Icon  
1/19/2021Bay Ltd. NomisMajor ShareholderSell50,000$19.81$990,500.006,253,532View SEC Filing Icon  
1/14/2021Bay Ltd. NomisMajor ShareholderSell25,000$18.07$451,750.006,253,532View SEC Filing Icon  
1/11/2021Bay Ltd. NomisMajor ShareholderSell10,423$19.00$198,037.006,293,109View SEC Filing Icon  
12/28/2020Bay Ltd. NomisMajor ShareholderSell500$22.20$11,100.006,303,532View SEC Filing Icon  
12/23/2020Bay Ltd. NomisMajor ShareholderSell45,000$21.09$949,050.006,312,433View SEC Filing Icon  
12/21/2020Bay Ltd. NomisMajor ShareholderSell25,000$19.46$486,500.006,469,733View SEC Filing Icon  
12/18/2020Bay Ltd. NomisMajor ShareholderSell62,700$15.76$988,152.006,469,733View SEC Filing Icon  
7/20/2020Bay Ltd. NomisMajor ShareholderSell300,000$5.00$1,500,000.00
6/16/2020Bay Ltd. NomisMajor ShareholderSell65,000$5.63$365,950.00
See Full Table
Insider Selling at Humanigen?
Sign-up to receive's daily insider buying and selling report for Humanigen and related companies.

SEC Filings (Institutional Ownership Changes) for Humanigen (NASDAQ:HGEN)

38.30% of Humanigen stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at HGEN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Humanigen Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/19/2021Virtu Financial LLC24,911$0.48M0.0%+45.5%0.042%Search for SEC Filing on Google Icon
5/19/2021Think Investments LP1,637,808$31.28M5.3%+22.4%2.792%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC709,139$13.55M0.0%+1,171.5%1.209%Search for SEC Filing on Google Icon
5/18/2021Luminus Management LLC340,221$6.50M1.2%N/A0.580%Search for SEC Filing on Google Icon
5/18/2021Morgan Stanley6,492$0.12M0.0%-60.7%0.011%Search for SEC Filing on Google Icon
5/18/2021Cormorant Asset Management LP1,000,000$19.10M0.4%N/A1.705%Search for SEC Filing on Google Icon
5/18/2021Cubist Systematic Strategies LLC22,024$0.42M0.0%N/A0.038%Search for SEC Filing on Google Icon
5/17/2021Royal Bank of Canada6,900$0.13M0.0%+21.1%0.012%Search for SEC Filing on Google Icon
5/17/2021Walleye Capital LLC91,206$1.74M0.1%N/A0.155%Search for SEC Filing on Google Icon
5/17/2021HRT Financial LP162,373$3.10M0.0%N/A0.277%Search for SEC Filing on Google Icon
5/17/2021Goldman Sachs Group Inc.74,030$1.41M0.0%N/A0.126%Search for SEC Filing on Google Icon
5/14/2021Monashee Investment Management LLC150,000$2.87M0.4%N/A0.256%Search for SEC Filing on Google Icon
5/14/2021Credit Suisse AG12,763$0.24M0.0%N/A0.022%Search for SEC Filing on Google Icon
5/13/2021Trexquant Investment LP30,604$0.59M0.1%N/A0.052%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp21,794$0.42M0.0%-10.1%0.037%Search for SEC Filing on Google Icon
5/13/2021Citigroup Inc.272,452$5.20M0.0%+1,314.0%0.464%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp78,076$1.49M0.0%+5.5%0.133%Search for SEC Filing on Google Icon
5/12/2021M Holdings Securities Inc.96,900$1.85M0.2%-11.8%0.165%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC367,325$7.02M0.0%+3.8%0.626%Search for SEC Filing on Google Icon
5/12/2021CM Management LLC25,000$0.48M0.4%-37.5%0.043%Search for SEC Filing on Google Icon
5/12/2021JPMorgan Chase & Co.15,000$0.29M0.0%N/A0.026%Search for SEC Filing on Google Icon
5/12/2021E Fund Management Co. Ltd.8,628$0.17M0.0%N/A0.015%Search for SEC Filing on Google Icon
5/12/2021UBS Group AG88,678$1.69M0.0%N/A0.151%Search for SEC Filing on Google Icon
5/10/2021Rafferty Asset Management LLC207,329$3.96M0.0%N/A0.353%Search for SEC Filing on Google Icon
5/10/2021Bank Julius Baer & Co. Ltd Zurich1,500$29K0.0%N/A0.003%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.792,127$15.13M0.0%+0.2%1.350%Search for SEC Filing on Google Icon
4/27/2021Belvedere Trading LLC22,386$0.43M0.0%N/A0.042%Search for SEC Filing on Google Icon
4/27/2021AE Wealth Management LLC22,000$0.42M0.0%N/A0.041%Search for SEC Filing on Google Icon
4/12/2021HighPoint Advisor Group LLC17,400$0.30M0.0%N/A0.033%Search for SEC Filing on Google Icon
4/5/2021Pacer Advisors Inc.4,850$93K0.0%N/A0.009%Search for SEC Filing on Google Icon
3/9/2021tru Independence LLC154,270$2.70M0.0%N/A0.299%Search for SEC Filing on Google Icon
2/26/2021M Holdings Securities Inc.109,900$1.92M0.2%+11.8%0.213%Search for SEC Filing on Google Icon
2/24/2021Virtu Financial LLC17,119$0.30M0.0%N/A0.033%Search for SEC Filing on Google Icon
2/16/2021Charles Schwab Investment Management Inc.186,843$3.27M0.0%N/A0.362%Search for SEC Filing on Google Icon
2/12/2021Virtus ETF Advisers LLC24,667$0.43M0.2%N/A0.048%Search for SEC Filing on Google Icon
2/11/2021Northern Trust Corp74,016$1.30M0.0%N/A0.143%Search for SEC Filing on Google Icon
2/11/2021Citigroup Inc.19,268$0.34M0.0%N/A0.037%Search for SEC Filing on Google Icon
2/9/2021Wells Fargo & Company MN24,319$0.43M0.0%N/A0.047%Search for SEC Filing on Google Icon
2/9/2021Bank of New York Mellon Corp24,234$0.42M0.0%N/A0.047%Search for SEC Filing on Google Icon
2/8/2021IFG Advisory LLC13,000$0.23M0.0%N/A0.025%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.790,602$13.84M0.0%+12.8%1.532%Search for SEC Filing on Google Icon
2/5/2021CM Management LLC40,000$0.70M0.6%N/A0.077%Search for SEC Filing on Google Icon
2/3/2021Winslow Evans & Crocker Inc.8,250$0.14M0.0%N/A0.016%Search for SEC Filing on Google Icon
11/17/2020VR Adviser LLC2,332,516$24.82M4.9%N/A4.519%Search for SEC Filing on Google Icon
11/17/2020Polar Capital LLP825,000$8.78M0.1%N/A1.598%Search for SEC Filing on Google Icon
11/16/2020Point72 Asset Management L.P.500,000$5.32M0.0%N/A0.969%Search for SEC Filing on Google Icon
11/16/2020ExodusPoint Capital Management LP32,423$0.35M0.0%N/A0.063%Search for SEC Filing on Google Icon
11/16/2020M Holdings Securities Inc.98,300$1.05M0.2%N/A0.190%Search for SEC Filing on Google Icon
11/13/2020First Light Asset Management LLC400,000$4.26M0.4%N/A0.775%Search for SEC Filing on Google Icon
11/9/2020Caas Capital Management LP31,052$0.33M0.0%N/A0.062%Search for SEC Filing on Google Icon
11/6/2020BlackRock Inc.700,940$7.46M0.0%N/A1.397%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Humanigen, Inc., a clinical stage biopharmaceutical company, develops a portfolio of immuno-oncology and immunology monoclonal antibodies in the United States. The company's lead product candidate is Lenzilumab, a monoclonal antibody that targets and neutralizes human granulocyte-macrophage colony-stimulating factor, which is in Phase III clinical trial for the treatment of cytokine storm associated with COVID-19; and Phase Ib/II clinical trial as a sequenced therapy in combination with CD19 targeted chimeric antigen receptor T-cell therapies to treat patients with relapsed or refractory B-cell lymphoma, as well as that has completed Phase I clinical trial in patients with chronic myelomonocytic leukemia. It also develops Ifabotuzumab, a humaneered monoclonal antibody that targets EphA3 receptor, which has completed the Phase I dose escalation portion of a Phase I/II clinical trial in multiple hematologic malignancies; and HGEN005, an anti-EMR1 monoclonal antibody, which is in pre-clinical stage for the treatment of eosinophilic disorders. Humanigen, Inc. has a clinical collaboration agreement with Kite Pharma, Inc. to conduct a multi-center Phase Ib/II study of Lenzilumab in patients with relapsed or refractory diffuse large B-cell lymphoma; and a cooperative research and development agreement with the Department of Defense to assist in the development of lenzilumab in advance of a potential emergency use authorization for COVID-19. The company was formerly known as KaloBios Pharmaceuticals, Inc. and changed its name to Humanigen, Inc. in August 2017. Humanigen, Inc. was incorporated in 2000 and is based in Burlingame, California.
Read More on Humanigen

Today's Range

Now: $16.06
Low: $15.76
High: $16.67

50 Day Range

MA: $18.35
Low: $16.19
High: $22.74

52 Week Range

Now: $16.06
Low: $7.50
High: $29.20


40,709 shs

Average Volume

1,886,787 shs

Market Capitalization

$948.89 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Humanigen?

Humanigen's top insider shareholders include:
  1. Bay Ltd Nomis (Major Shareholder)
  2. Edward P Jordan (Insider)
  3. Cameron Durrant (CEO)
  4. Dale Chappell (Insider)
  5. Dale Chappell (Major Shareholder)
Seattle company’s cannabis candies could fuel boom in stock shares
A popular Seattle cannabis manufacturer recently announced the roll-out of an all-new line of premium infused edibles, marketed under the brand name “Goodies.” Hand-crafted, gluten-free, and using all-natural ingredients, the candies and caramels contain micro-dose servings of just 5-mg THC for a controlled, measured experience.
Get a FREE report on new pot stock blockbuster